跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 21,255 条关于
“SCENESSE®”
全部
21,255
临床试验
17,614
药物
995
机构
3
资讯
2,643
2个月前
SCENESSE® (Afamelanotide) Approved by Health Canada for Erythropoietic Protoporphyria
去年
CLINUVEL Seeks Canadian Approval for SCENESSE® in Erythropoietic Protoporphyria
去年
Clinuvel Advances Phase III Trial for Vitiligo Treatment with SCENESSE®, Recruiting Over 200 Patients
去年
CLINUVEL CEO Returns to Drive US Expansion with Vitiligo Treatment Approval Strategy
去年
Disc Medicine Announces End-of-Phase 2 Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria
11个月前
CLINUVEL Advances Novel Sustained-Release Peptide Formulations to Preclinical Testing
去年
Disc Medicine Advances Hematology Pipeline with Bitopertin NDA Plans and Phase 2 Trials
去年
Clinuvel Seeks EMA Approval for Increased SCENESSE Dosage in Europe
去年
Patient-Researcher's Journey Leads to Breakthrough Treatment for Rare Light Sensitivity Disorder
去年
Disc Medicine's Bitopertin Poised for Potential Accelerated FDA Approval in Erythropoietic Protoporphyria
第 1 页,共 265 页
上一页
下一页